Skip to content

Clinical evaluation of Nagaradi yoga in the management of Tamakashwasa w.s.r. to Bronchial Asthma

The Clinical Evaluation Of Nagaradi Yoga In The Management Of Tamaka Shwasa(Bronchial Asthma)-An Open Labelled Single Group Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099613
Enrollment
30
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J980- Diseases of bronchus, not elsewhere classified

Interventions

None listed

Sponsors

Government Akhandanand Ayurveda college and hospital Bhadra Ahmedabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known case of bronchial Asthma or patients with classical signs and symptoms of Tamaka Shwasa described in ancient Ayurveda text Shwasakrichchhata(dyspnoea) Ghurghurukama (wheezing sound) Kasa (cough) Asamyakanidra (disturbed sleep) Kanthodhwansa (hoarseness of voice) pinasa (rhinitis) Shleshma Vimokshante Muhurtam sukham (after expectoration patient feels better ) parshva avgrihyate (chest tightness) Asino labhate sukham (get relief with sitting posture) PEFmore than or equal to 50

Exclusion criteria

Exclusion criteria: patient suffering from the systemic or serious illness like Emphysema,diabetes mellitus,hypertension, renal diseases and cardiac diseases. patients of COPD , cardiac asthma and severe exacerbation. Any acute systemic disease or infection with post covid lung disease or complication. Pregnant and lactating mothers. Any malignancy. Acute and serious conditions require intervention will be excluded. PEF less than 50 Patients on immunosuppressive or long term steriods therapy. Psychiatric illness or noncooperative behavior. Participation in another clinical trial.

Design outcomes

Primary

MeasureTime frame
Results will be assessed on the basis of gradation of clinical features of Tamaka ShwasaTimepoint: 2 weeks of completion of clinical trial or treatment

Secondary

MeasureTime frame
Peak flow meter reading to access improvement of lung functionsTimepoint: 2 weeks of completion of clinical trial or treatment

Countries

India

Contacts

Public ContactDr Anamika Soni

Government Akhandanand Ayurveda college

ayursoni@yahoo.com8209199183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026